Get started
EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO)EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO)EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO)

EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PHAR chart


Full chart

PHAR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.14 B‬ EGP
Dividend yield (indicated)
4.17%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪822.32 M‬ EGP
Revenue (FY)
‪5.23 B‬ EGP
Shares float
‪74.37 M‬
Beta (1Y)
0.37

About EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO)


Sector
Health Technology
CEO
Ahmed Said Mohammed Kilany El-Bucheiry
Headquarters
Tenth of Ramadan City
Website
eipico.com.eg
Founded
1980
ISIN
EGS38081C013
FIGI
BBG000G1YHR5
Egyptian International Pharmaceutical Industries Co. engages in the manufacture and distribution of medicines and other medical products. Its products include anesthetics, analgesics, antibiotics, antacids, decongestants, diuretics, laxatives, blood substitutes, vitamins, and minerals. The company was founded on December 3, 1980, and is headquartered in Tenth of Ramadan City, Egypt.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

PHAR news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PHAR is 48.000 EGP — it has increased by 0.80% in the past 24 hours. Watch EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) stocks are traded under the ticker PHAR.
PHAR stock has fallen by −0.06% compared to the previous week, the month change is a −2.12% fall, over the last year EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) has showed a 23.55% increase.
We've gathered analysts' opinions on EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) future price: according to them, PHAR price has a max estimate of 87.80 EGP and a min estimate of 38.79 EGP. Watch PHAR chart and read a more detailed EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) stock forecast: see what analysts think of EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) and suggest that you do with its stocks.
PHAR reached its all-time high on Jan 2, 2018 with the price of 94.146 EGP, and its all-time low was 4.184 EGP and was reached on May 12, 2003. View more price dynamics on PHAR chart.
See other stocks reaching their highest and lowest prices.
PHAR stock is 1.20% volatile and has beta coefficient of 0.37. Track EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) stock price on the chart and check out the list of the most volatile stocks — is EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) there?
Today EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) has the market capitalization of ‪7.14 B‬, it has decreased by −1.98% over the last week.
Yes, you can track EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) financials in yearly and quarterly reports right on TradingView.
EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
PHAR net income for the last quarter is ‪175.57 M‬ EGP, while the quarter before that showed ‪603.34 M‬ EGP of net income which accounts for −70.90% change. Track more EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) financial stats to get the full picture.
EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) dividend yield was 5.38% in 2023, and payout ratio reached 36.18%. The year before the numbers were 5.48% and 30.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, PHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) stock shows the buy signal. See more of EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.